Perforin and Fas/FasL cytolytic pathways at the maternal-fetal interface

American Journal of Reproductive Immunology

Volumn 54, Issue 5, 2005, Pages 241-248

  Crncic, Tatjana Bogovic ^a   Laskarin, Gordana ^a   Juretic, Koraljka ^a   Strbo, Natasa ^a   Dupor, Jana ^a   Srsen, Suzana ^a   Randic, Ljiljana ^a   Le Bouteiller, Philippe ^b   Tabiasco, Julie ^b   Rukavina, Daniel ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b CHU PURPAN   (France)

Author keywords

Cytotoxicity; Decidua; Fas FasL; Perforin

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CYTOKINE; FAS ANTIGEN; FAS LIGAND; PERFORIN;

ALLOGRAFT; ANIMAL CELL; CELL LINE; CYTOLYSIS; CYTOTOXICITY; DECIDUA; FETOPLACENTAL UNIT; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MEDIATOR; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL; TROPHOBLAST;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD95; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FEMALE; HUMANS; K562 CELLS; LYMPHOCYTE SUBSETS; MALE; MATERNAL-FETAL EXCHANGE; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; PREGNANCY; RECEPTORS, IGG; RECEPTORS, TUMOR NECROSIS FACTOR; TROPHOBLASTS; TUMOR NECROSIS FACTORS;

EID: 27544453776     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00320.x     Document Type: Review

References (68)

1. Balkow S, Kersten A, Tran TT, Stehle T, Grosse P, Museteanu C, Utermohlen O, Pircher H, von Weizsacker F, Wallich R, Mullbacher A, Simon MM: Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol 2001; 75:8781-8791.
2. Lieberman J: The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003; 3:361-370.
3. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2:735-747.
4. Metkar SS, Wang B, Aguilar-Santelises M, Raja SM, Uhlin-Hansen L, Podack E, Trapani JA, Froelich CJ: Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 2002; 16:417-428.
5. Thome M, Tschopp J: Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001; 1:50-58.
6. Froelich CJ, Orth K, Turbov J, Seth P, Gottlieb R, Babior B, Shah GM, Bleackley RC, Dixit VM, Hanna W: New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem 1996; 271:29073-29079.
7. Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER: Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 1996; 157:1919-1925.
8. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
9. Nakajima H, Golstein P, Henkart PA: The target cell nucleus is not required for cell-mediated granzyme-or Fas-based cytotoxicity. J Exp Med 1995; 181: 1905-1909.
10. Scaffidi C, Krammer PH, Peter ME: Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. Methods 1999; 17: 287-291.
11. Tschopp J, Irmler M, Thome M: Inhibition of fas death signals by FLIPs. Curr Opin Immunol 1998; 10:552-558.
12. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997; 326:1-16.
13. Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G: Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 2000; 106:1209-1220.
14. Petrovic O, Gudelj L, Rubesa G, Haller H, Beer AE, Rukavina D: Decidual trophoblast interactions: decidual lymphoid cell function in normal anembryonic, missed abortion and ectopic human pregnancy. J Reprod Immunol 1994; 26:217-231.
15. Moffett A, Loke YW: The immunological paradox of pregnancy: a reappraisal. Placenta 2004; 25:1-8.
16. Rukavina D, Rubesa G, Gudelj L, Podack ER: Human decidual lymphocytes: phenotype, perforin expression, and function. Reg Immunol 1994; 6:320-325.
17. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
18. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198:1201-1212.
19. Rukavina D, Rubesa G, Gudelj L, Haller H, Podack ER: Characteristics of perforin expressing lymphocytes within the first trimester decidua of human pregnancy. Am J Reprod Immunol 1995; 33:394-404.
20. Gulan G, Podack ER, Rukavina D, Gudelj L, Rubesa G, Petrovic O, Johnson PM, Christmas SE: Perforin-expressing lymphocytes in peripheral blood and decidua of human first-trimester pathological pregnancies. Am J Reprod Immunol 1997; 38:9-18.
21. Gudelj L, Christmas SE, Laskarin G, Johnson PM, Podack ER, Rukavina D: Membrane phenotype and expression of perforin and serine esterases by CD3-peripheral blood and decidual granular lymphocyte-derived clones. Am J Reprod Immunol 1997; 38: 162-167.
22. Rukavina D, Podack ER, Rubesa G, Spanjol-Pandelo S, Randic LJ: Down regulated expression of perforin positive/CD16+ cells in the peripheral blood lymphocytes in the first trimester of pregnancy and upregulation at the end of pregnancy. Am J Reprod Immunol 1997; 38:189-196.
23. King A, Birkby C, Loke YW: Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118:337-344.
24. King A, Loke YW: Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2-stimulated decidual NK cells. Cell Immunol 1990; 129:435-448.
25. Bogovic Crncic T, Strbo N, Laskarin G, Cupurdija K, Dorcic D, Juretic K, Dupor J, Sotosek Tokmadzic V, Vlastelic I, Randic LJ, Rukavina D: Decidual NK cells use Fas/FasL cytolytic pathway. Am J Reprod Immunol 2004; 51:490 (abstract P37).
26. Avril T, Iochmann S, Brand D, Bardos P, Watier H, Thibault G: Human choriocarcinoma cell resistance to natural killer lysis due to defective triggering of natural killer cells. Biol Reprod 2003; 69:627-633.
27. Selam B, Kayisli UA, Mulayim N, Arici A: Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol Reprod 2001; 65:979-985.
28. Hammer A, Dohr G: Expression of Fas-ligand in first trimester and term human placental villi. J Reprod Immunol 2000; 46:83-90.
29. Mor G, Gutierrez LS, Eliza M, Kahyaoglu F, Arici A: Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol 1998; 40:89-94.
30. Hunt JS, Vassmer D, Ferguson TA, Miller L: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997; 158:4122-4128.
31. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S: Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 1996; 81:3119-3122.
32. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G: First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 2004; 10:55-63.
33. Blott EJ, Bossi G, Clark R, Zvelebil M, Griffiths GM: Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail. J Cell Sci 2001; 114:2405-2416.
34. Payne SG, Smith SC, Davidge ST, Baker PN, Guilbert LJ: Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol Reprod 1999; 60:1144-1150.
35. Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G: Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod 2002; 66:1853-1861.
36. Blaschitz A, Hutter H, Dohr G: HLA Class I protein expression in the human placenta. Early Pregnancy 2001; 5:67-69.
37. Rukavina D, Podack ER: Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant? Immunol Today 2000; 21:160-163.
38. Rukavina D, Vince G: Roles of cytokines and immune cells at the interface - a workshop report. Placenta 2000; 21 (Suppl. A) Trophoblast Research, 14, S97-S98.
39. Bonnema JD, Rivlin KA, Ting AT, Schoon RA, Abraham RT, Leibson PJ: Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J Immunol 1994; 152:2098-2104.
40. Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW: Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 1994; 153:4427-4435.
41. von Rango U, Classen-Linke I, Raven G, Bocken F, Beier HM: Cytokine microenvironments in human first trimester decidua are dependent on trophoblast cells. Fertil Steril 2003; 79:1176-1186.
42. Rukavina D, Laskarin G, Strbo N, Sotosek V, Bedenicki I, Podack ER: Cytokines and hormones in the regulation of perform expression in the decidual lymphocytes. Period Biol 1998; 100(Suppl. 3):41.
43. Strbo N, Laskarin G, Sotosek V, Randic LJ, Rukavina D: Regulation of cytolytic activity of decidual lymphocytes: role of cytokines IL-2 and IL-15. Placenta 1999; 20:A64 (abstract).
44. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-276.
45. Salcedo TW, Azzoni L, Wolf SF, Perussia B: Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells. J Exp Med 1993; 177:1475-1480.
46. Zourbas S, Dubanchet S, Martal J, Chaouat G: Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the foetomaternal interface during murine pregnancy. Clin Exp Immunol 2001; 126:519-528.
47. Devergne O, Coulomb-L'Hermine A, Capel F, Moussa M, Capron F: Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 2001; 159:1763-1776.
48. Hayakawa S, Nagai N, Kanaeda T, Karasaki-Suzuki M, Ishii M, Chishima F, Satoh K: Interleukin-12 augments cytolytic activity of peripheral and decidual lymphocytes against choriocarcinoma cell lines and primary culture human placental trophoblasts. Am J Reprod Immunol 1999; 41:320-329.
49. Bogovic T, Sotosek V, Laskarin G, Cupurdija K, Randic LJ, Podack ER, Rukavina D: Cytolytic activity of decidual lymphocytes in response to short and long term IL-12, IL-15 and IL-18 stimulation. Am J Reprod Immunol 2001; 46:51 (abstract WP3-5).
50. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180:1395-1403.
51. Nguyen QH, Roberts RL, Ank BJ, Lin SJ, Thomas EK, Stiehm ER: Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell Immunol 1998; 185:8392.
52. Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H: Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999; 163:1906-1913.
53. Verma S, Hiby SE, Loke YW, King A: Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000; 62:959-968.
54. Dunn CL, Critchley HO, Kelly RW: IL-15 regulation in human endometrial stromal cells. J Clin Endocrinol Metab 2002; 87:1898-1901.
55. Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H: IL-15 expression at human endometrium and decidua. Biol Reprod 2000; 63:683-687.
56. Faust ZS, Laskarin G, Rukavina D, Szekeres-Bartho J: Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999; 42:71-75.
57. Laskarin G, Faust ZS, Strbo N, Sotosek V, Szekeres-Bartho J, Podack ER, Rukavina D: Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol 1999; 42: 312-320.
58. Laskarin G, Sotosek Tokmadzic V, Strbo N, Bogovic T, Szekeres-Bartho J, Randic LJ, Podack ER, Rukavina D: Progesterone-induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol 2002; 48:201-210.
59. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88-91.
60. Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, Hiroishi K, Takeda K, Tagawa Y, Iwakura Y, Kayagaki N, Kurimoto M, Okamura H, Hada T, Yagita H, Akira S, Nakanishi K, Higashino K: IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol 1999; 162:1662-1668.
61. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K: IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996; 157:3967-3973.
62. Sotosek V, Laskarin G, Strbo N, Dohr G, Blaschitz A, Podack ER, Rukavina D: Decidual macrophages are the population of decidual adherent cells which regulates perforin expression in cytolytic cells. Am J Reprod Immunol 1999; 42:76-82.
63. Laskarin G, Cupurdija K, Tokmadzic VS, Dorcic D, Dupor J, Juretic K, Strbo N, Crncic TB, Marchezi F, Allavena P, Mantovani A, Randic L, Rukavina D: The presence of functional mannose receptor on macrophages at the maternal-fetal interface. Hum Reprod 2005; 20:1057-1066.
64. Tokmadzic VS, Tsuji Y, Bogovic T, Laskarin G, Cupurdija K, Strbo N, Koyama K, Okamura H, Podack ER, Rukavina D: IL-18 is present at the maternal-fetal interface and enhances cytotoxic activity of decidual lymphocytes. Am J Reprod Immunol 2002; 48:191-200.
65. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J: A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53:241-256.
66. Ostojic S, Dubanchet S, Chaouat G, Abdelkarim M, Truyens C, Capron F: Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol 2003; 49:101-112.
67. Stallmach T, Ehrenstein T, Isenmann S, Muller C, Hengartner H, Kagi D: The role of perforin-expression by granular metrial gland cells in pregnancy. Eur J Immunol 1995; 25:3342-3348.
68. Spielman J, Lee RK, Podack ER: Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol 1998; 161:7063-7070.